Urgent Upgrades and Downgrades TSLA, PYPL, ANET + More Just Got Wall Street Attention

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  29 Apr 2025
 

Arista Networks ($ANET) received an important upgrade as a top Wall Street analyst dropped their bearish stance. The stock surged 3.50% to close at $81.08, signaling renewed institutional confidence. After a long stretch of cautious sentiment, this shift suggests a potential rebound play in the near term, particularly if tech momentum accelerates.

Crane Co. ($CR) jumped over 6% after UBS upgraded the stock, citing robust order flows and attractive M&A potential. With volume well above its average, investors clearly embraced the analyst’s bullish outlook. Crane’s business mix and macro exposure make it a compelling industrial name in this environment.

Keurig Dr Pepper ($KDP) saw a downgrade to "Hold" as analysts raised concerns over three critical headwinds facing the company. Despite eking out a modest 0.34% gain today, the downgrade reflects deeper concerns over valuation and strategic direction, making this a stock to watch cautiously.

Liberty Broadband ($LBRDA) traded above its average analyst target, triggering a downgrade signal. At $87.82, the stock may be running out of steam, as crossing this target often precedes a reassessment of upside potential. The downgrade could reflect concerns about stretched valuation in a consolidating media sector.

Avantor ($LH) was downgraded by Goldman Sachs following a 60% slide since 2021. Goldman admitted misjudging the impact of segment-specific challenges, and while the stock rallied nearly 5% today, this move appears more like a dead-cat bounce than a sustainable reversal.

ArcelorMittal ($MT) also crossed above its average price target and slipped 0.61%, signaling a downgrade amid concerns the stock may be overextended. In the materials sector, valuations are tightening, and MT recent move suggests investors should consider locking in profits.

Novartis ($NVS) beat Q1 earnings expectations with adjusted EPS of $2.28 vs. $2.10 estimated, and upgraded guidance has analysts feeling more optimistic. The stock rose 0.79% as the company reaffirms its leadership in the global pharma space. This upgrade reinforces confidence in both execution and outlook.

OGE Energy ($OGE) also crossed above its average analyst target, closing at $45.71. While technically a downgrade, the muted reaction (+0.53%) shows investors aren’t overly concerned—yet. Any further upside may be limited unless there's a catalyst to warrant new price discovery.

Okta ($OKTA) surged 7.36% after a new analyst coverage began on a bullish note. Paired with an upgrade, this dual analyst action shows confidence in the company’s repositioning efforts and improving fundamentals. After a rocky few quarters, sentiment may be shifting in Okta’s favor.

PayPal ($PYPL) moved higher by 2.40% alongside a strong showing from fintech peers, powered by earnings beat and fresh analyst upgrades. The narrative around PYPL is turning more constructive as cost controls and product innovation begin to gain traction.

Saia ($SAIA) was upgraded today but failed to participate in the broader rally, dropping slightly to $235.86. While the analyst support is noteworthy, the tepid price action might indicate investor hesitation given recent volatility in the transportation sector.

StoneCo ($STNE) crossed above its target price and slipped 0.74%, prompting a downgrade. The market reaction suggests this was expected, and further upside could be capped without renewed earnings momentum.

Tesla ($TSLA) remains one of the most hotly debated names on the Street today. Despite a 1.94% gain, sentiment remains mixed, with conflicting analyst takes: an upgrade from one firm, a downgrade from another, and even a reiterated “strong sell.” Tesla’s future narrative is fractured, and while bulls remain, bears are growing louder post-earnings.

Travere Therapeutics ($TVTX) rallied over 3% following a full EU approval for its kidney drug FILSPARI. A fresh buy rating reflects confidence in the drug’s commercial runway and potential to transform the company’s growth profile.

Valero Energy ($VLO) was upgraded on the back of valuation and underperformance versus peers. The 0.77% gain may just be the beginning as the stock looks poised to close its performance gap in the energy space.

Bottom line: While several names earned analyst upgrades today, Crane ($CR) stands out with a high-conviction call backed by fundamentals and momentum. Okta ($OKTA) also shows technical strength with renewed institutional interest. But the real battleground remains Tesla ($TSLA) love it or hate it, this stock is in motion, and traders ignoring it may miss the market’s next big move.